Wearable hip robot could bring stroke rehab home

NCT ID NCT07716475

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This trial tests whether a hip-assisted wearable robot can help stroke survivors improve their walking through at-home training sessions. Eight adults who have had a stroke and walk with a spastic hemiplegic gait will use the robot during four 30-minute sessions over two weeks, guided by a visiting therapist. Researchers will measure usability and walking improvements to see if this approach is practical and effective.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a hip-assisted wearable robot that assists hip movement during walking, used at home with a therapist
What this could lead to
If successful, this approach could offer a convenient, home-based rehabilitation option to improve walking after a stroke.
What could go wrong
This is a very small, early exploratory trial with only 8 participants, so results may not apply broadly. The device requires a visiting therapist, which may limit practicality.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Yongin Severance Hospital

    RECRUITING

    Yongin-si, Gyeonggi-do, 16995, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.